USCAP Lower Female Genital Tract Pathology: Practical Updates from the WHO and FIGO Classification and Reporting Systems 2025

USCAP Lower Female Genital Tract Pathology: Practical Updates from the WHO and FIGO Classification and Reporting Systems 2025

Regular price€100,00
/
Tax included. Shipping calculated at checkout.

  • Free Shipping on orders over 45$
  • In stock, ready to ship
  • Inventory on the way

USCAP Lower Female Genital Tract Pathology Practical Updates from the WHO and FIGO Classification and Reporting Systems 2025

Target Audience: practicing academic and community pathologists, and pathologists-in-training
Information:
Original release date: June 10, 2025

Course Description
This course is a comprehensive review of classification and reporting of lower female genital tract pathology (cervix, vagina, vulva), emphasizing updates from the new 5th edition World Health Organization classification system and new FIGO staging for cervical and vulvar cancers. Interactive microscopy cases will include biopsy specimens, resection specimens and cytopathological specimens. A practical approach to morphological assessment of neoplastic and non-neoplastic pathology will be complemented by strategies for selection and interpretation of key immunohistochemical stains and molecular diagnostic tests.

Target Audience

Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives

Upon completion of this educational activity, learners will be able to:
  • Apply the current W.H.O. criteria for morphological, immunohistochemical and molecular diagnostic classification of cervical and vulvar epithelial tumors, mesenchymal tumors, and their non-neoplastic mimics.
  • Assign the current FIGO staging criteria for cervical and vulvar carcinomas as well as the alternative Silva pattern of invasiveness for cervical adenocarcinoma.
  • Classify non-neoplastic inflammatory and melanocytic disorders of the vulva.
  • Diagnose exfoliative cytologic specimens of the cervix using current Bethesda system guidelines as well as pelvic fluid cytology specimens.

 

Topics:
  • Cervical Glandular Pathology – Joseph T. Rabban, MD, MPH
  • Cervical Squamous Pathology and HPV Screening – Christina S. Kong, MD
  • Vulvar Squamous Cell Carcinoma and Precursors – Stephanie Lynn Skala, MD
  • Non-Neoplastic Vulvar Pathology – Yuna Kang, MD medustudent.com
  • Cervical and Vulvar Mesenchymal Pathology – Oluwole Fadare, MD
  • Cervical and Pelvic Cytopathology – Paul N. Staats, MD
  • FREE SECTION: Lower Anogenital Squamous Terminology (LAST) Guideline Update

- Orders under 45$ will have a shipping charge of a flat rate of 15$.

-Orders over 45$ will have Free Shipping.

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.

Testimonials

★★★★★


“I find the taste of Moringa tea to be very refreshing and it definitely gives me a feeling of ‘wellness’. I appreciate the ethics of the company. Am looking forward to trying the cream”

Elain
★★★★★


”I love knowing that everything is 100% chemical-free and tested in Canada. I also respect the sustainable farming approach that supports both Canada and Ethiopia.”

Alycia
★★★★★

Since I drink Moringa Tea I feel so much better. My mouth was always so dry but since I drink this tea I have so much saliva I drool.

I cannot believe how much it has helped me with my breathing. I love it. I even eat all the leaves - Thank you for introducing me to this herbal tea. I'm 85 years old.

Richard Dorge
Winnipeg, MB

Recently viewed